tion of the pituitary activity by estrogenic substance extends to other pituitary hormones. Thus, in cases of climacteric thyrotoxicosis, Hoet and Gessler (4) were able to effect a reduction in the basal metabolic rate from around plus 50 to norrnal by injections of large amounts of estrogenic substance. It is probable that the thyrotoxicosis in these cases was due to increased production of thyrotropic hormone.
There is both experimental and clinical evidence that the anterior pituitary plays an important role in carbohydrate metabolism. Houssay (1) demonstrated that hypophysectomy alleviates the diabetic symptoms occurring after pancreatectomy. Young (2) has produced a permanent diabetic condition in dogs by injections of anterior pituitary extract. Syndromes due to hyperfunction of the pituitary, like acromegaly and Cushing's disease, often include hyperglycemia. In Simmonds' disease, in which there is decrease of pituitary function, hypoglycemia often occurs, as is the case with hypophysectomized animals. Such evidence indicates that when the pituitary is overactive there is likely to be hyperglycemia, and when it is underactive, hypoglycemia. This influence of the anterior pituitary has been attributed to a "diabetogenic factor"; and it is possible that increased pituitary activity in this respect plays a role in some cases of diabetes mellitus.
It is known that an antagonism exists between the stimulating hormones of the anterior pituitary and the hormones of the glands stimulated by the pituitary. This antagonism is demonstrable particularly in relation to the gonads. Thus it has been shown that gonadectomy results in an increased production of gonadotropic hormone by the anterior pituitary, while the injection of estrogenic substance prevents this overactivity or inhibits it once it has occurred. In humans the changes occurring at the menopause have been demonstrated by Albright (3) and others to consist of a decrease of ovarian estrogenic hormone and an increase of gonadotropic hormone. These changes can be rectified by injections of estrogenic substance. Moreover, it is probable that inhibi- ' The expenses of this investigation were defrayed in part by a grant to Harvard University from the Smith, Kline & French Laboratories, Philadelphia.
2Graduate Fellow of the Belgian-American Educational Foundation, 1937 to 1939. tion of the pituitary activity by estrogenic substance extends to other pituitary hormones. Thus, in cases of climacteric thyrotoxicosis, Hoet and Gessler (4) were able to effect a reduction in the basal metabolic rate from around plus 50 to norrnal by injections of large amounts of estrogenic substance. It is probable that the thyrotoxicosis in these cases was due to increased production of thyrotropic hormone.
The effect of injections of estrogenic substance in diabetic conditions has been tested both experimentally and clinically. Barnes, Regan and Nelson (5) and Nelson and Overholser (6) improved the sugar tolerance and definitely prolonged life in depancreatized dogs (5) and monkeys (6) by estrin injections. Attempts also have been made to influence human diabetes. In 1928 Rathery and Rudolf (7) and Carnot, Terris and Caroli (8) claimed to have produced improvement in diabetic women by injections of estrin. The doses employed were so minute, however, (10 units) that it is unlikely that the changes which occurred were due to the influence of this small amount of estrogenic substance. Mazer, Meranze and Israel (9) have come to the conclusion that the blood sugar level of normal women remains unaffected by injections of large doses of estrogenic substance, but that the blood and urine of diabetic women who are subjected to similar treatment will show an appreciable decrease in the sugar content. These workers give little detailed information concerning their 3 patients except for the fact that the maximum fall observed in the fasting blood sugar values was 60 mgm. per 100 cc. Jones and MacGregor (10) injected 10 non-diabetic women past the menopause with large doses of estrin without any effect on the blood sugar. In 1936 Collens, SloBodkin, Rosenbliett and Boas ( 11 ) gave 7 diabetic patients injections of estrogenic substance and came to the conclusion that this procedure had 715 absolutely no effect on human diabetes. They used daily doses varying between 100 and 400 rat units. Glen and Eaton (12) improved the condition of a severely diabetic woman, in whom the diabetes apparently started after an ovariectomy, by injections of estrogenic substance. In this case there was said to be an increased amount of diabetogenic hormone in the blood, as tested by the method of De Wesselow and Griffiths (13) .
One possible explanation for the conflicting reports in the literature may be the present inability to discriminate between those diabetics in whom the pituitary may have played an etiological role and those with purely pancreatic diabetes. If estrogenic substance can exert an influence on diabetes, such an effect theoretically should be demonstrable more easily at a life period when the organism is lacking in ovarian estrogenic hormone. With this in mind, it was decided to study the effect of injected estrogenic substance on the blood sugar of diabetic women who had passed the menopause.
METHODS
Five female diabetic patients who had passed the menopause were chosen for study. Two of these women (Cases 1 and 2) gave an unequivocal history of the simultaneous onset of the menopause and diabetes. In Case 3 menopause symptoms preceded by two years the detection of diabetes at the time of a panhysterectomy. In Case 4 the correlation was difficult to ascertain, but it is probable that the diabetes began shortly before the menses became irregular, amenorrhea occurring four years yater. In Case 5 the menopause preceded the sudden onset of diabetes by seven years.
The general experimental plan was as follows: In each instance the patient was maintained throughout the entire period of observation on a diet containing 151 5 . Throughout the entire period of observation the fasting blood sugar values were determined at frequent intervals on venous blood (Folin method). For convenience the experimental results in each case are discussed separately.
In 2 patients an attempt was made to determine whether they belonged, according to the method of Himsworth (14), to insulin-sensitive or insulin-insensitive types, respectively. In 4 patients urine assays for follicle-stimulating pituitary hormone were made both before and after the period of injection of estradiolbenzoate. Finally, the influence of these injections on the basal metabolic rate was determined in two instances.
RESULTS
Case 1. This 50-year-old white woman was found to have diabetes at the time of the menopause, six months previous to admission to the hospital. The diabetic condition was controlled by 30 units of protamine insulin a day. The results of this observation are given in Figure 1 . During the eleven-day control period without insulin the fasting blood sugar values rose. During the first three days of the subsequent experimental period daily injections of 10,000 international units (1 cc.) of estradiolbenzoate were given, without any effect on the fasting blood sugar. The daily dose was then increased to 20,000 international units (2 cc.) and continued at this level for twelve days, again with no effect on the fasting blood sugar values. After an interval of four days, 50,000 international units of estradiolbenzoate (1 cc.) were injected daily for six days. The The general condition of this patient was remarkably improved. She had suffered considerable pain from hypertrophic arthritis of both knees for one year. When first seen, she walked with difficulty. After the first four injections of estradiolbenzoate she volunteered the information that her arthritis had improved to such an extent that she could walk much better and could freely bend her right knee, which was previously stiff. Similar effects have been reported by Hall (15) in menopause arthralgia.
On the fifty-fifth day, while the fasting blood sugar was going up, the patient was discharged. Owing to her intelligence and cooperation it was possible to maintain the same diet at home and to continue the investigation. The results of the further observations are given in Figure 2B . On the sixty-sixth day 100,000 international units of estradiolbenzoate (2 cc.) were injected. This was followed the next day by metrorrhagia of three days' duration. On the seventy-third day the patient received an injection of 50,000 international units of estradiolbenzoate (1 cc.) and from then on this amount was given twice a week. Case 3. This 40-year-old white woman began to experience menstrual irregularities four years before entry to the hospital. Two years later a panhysterectomy was performed disclosing, according to a pathologist's report, late proliferating endometrium, early squamous cell carcinoma of the cervix, and thecal lutein cysts of the ovaries. On the day before operation she was found to have diabetes, which required 10 units of insulin and 15 units of protamine insulin daily for regulation when the patient entered the hospital for the present observations. As shown in Figure 3, when the injections were discontinued, the data suggest that the fasting blood sugar was a little higher than during the injection period. Case 4. This 54-year-old white woman apparently became diabetic eight years before entry to the hospital and shortly before the menses became irregular. Amenorrhea occurred four years later. The diabetic condition was controlled by 30 units of protamine insulin a day. The results of this observation are given in Figure 4 . Figure 5 . During a nine-day control period without insulin her fasting blood sugar averaged about 150 mgm. per 100 cc. During the subsequent experimental period daily injections of 50,000 international units for eight days and of 100,000 international units of estradiolbenzoate for three additional days did not prevent further increases in the fasting blood sugar level, which reached a maximum of 217.7 mgm. per 100 cc. on the ninth day of the experimental period.
Glucose tolerance. Glucose tolerance tests in our patients gave typical diabetic curves. Fifty grams of glucose were given orally instead of breakfast; samples of venous blood were taken every half hour for two or three hours, the patient remaining in bed during the test. An attempt was made in two of our cases to differentiate them according to Himsworth (14) (21) and Taubenhaus (22) .
SUMMARY
Five diabetic women who had passed the menopause were given intramuscular injections of estradiolbenzoate (50,000 international units daily). In the four instances tested, the excretion of follicle-stimulating hormone of the pituitary was significantly decreased by this procedure. A significant lowering of the fasting blood sugar resulted in 2 of the patients (Cases 1 and 2) in whom the onset of diabetes coincided with the menopause, and probably in a third (Case 3) in whom the menopause preceded the diabetes. It is suggested that this effect was due to inhibition by the injected estradiolbenzoate of a postmenopausal excessive production of the pituitary diabetogenic factor. In the other 2 patients (Cases 4 and 5), there was clearly no effect from the estradiolbenzoate injections. In Case 4 the onset of diabetes preceded the menopause and in Case 5 the menopause preceded the onset of diabetes by at least seven years.
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